Document 0151
 DOCN  M9580151
 TI    Tuberculosis in children.
 DT    9506
 AU    Costello AM; Rook G; University of London, UK.
 SO    Curr Opin Pediatr. 1995 Feb;7(1):6-12. Unique Identifier : AIDSLINE
       MED/95245401
 AB    Tuberculosis in children is a growing problem, both globally and in many
       industrialized countries. With a rising incidence, clinicians will again
       face the challenge of the myriad presentations of tuberculous disease.
       Multidrug resistance and HIV coinfection present additional
       complications. Renewed interest in tuberculosis among scientists has led
       to progress in our understanding of antimycobacterial effector
       mechanisms, the regulation of Th1 and Th2 immune responses, virulence
       factors, and the potential for immunotherapeutic agents to reduce the
       duration of antituberculous therapy.
 DE    Animal  Child  Human  T-Lymphocytes, Suppressor-Effector/PHYSIOLOGY
       *Tuberculosis/EPIDEMIOLOGY/PHYSIOPATHOLOGY/THERAPY  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).